Brief: BetterLife Pharma Says Entered Into Exclusivity Agreement With Altum Pharmaceuticals
11/06/2020 12:20
June 11 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE PHARMA UPDATES SHAREHOLDERS ON ITS PROPOSED
ACQUISITION OF ALTUM
* BETTERLIFE PHARMA INC - ENTERED INTO AN EXCLUSIVITY
AGREEMENT
WITH ALTUM PHARMACEUTICALS INC.
* BETTERLIFE PHARMA INC - AMENDED MAY 6 ALTUM DEAL TERMS TO
ACQUIRE WORLDWIDE RIGHTS TO COMMERCIALIZE, SELL AP-003,
POTENTIAL COVID-19 TREATMENT
Source text for Eikon: ID:nCNWC4Cw5a
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units